Nitric Oxide + Collagen Delivery

About Jellagen

Jellagen is pioneering a novel biomaterial platform using jellyfish-derived Collagen Type 0, offering a versatile, safe, and translatable alternative to traditional mammalian collagens. Its technology targets the high-growth regenerative medicine sector with applications in wound care, orthopedics, and cell culture. The company is building a strong scientific foundation through peer-reviewed publications and has announced strategic partnerships, positioning itself as an innovator in next-generation medical treatments. Jellagen operates as a private, likely pre-revenue entity, advancing its platform through research and development collaborations.

Therapeutic Areas

Other Not Specified Drugs